Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications

por Gonzalez-Ortiz, Fernando, Kac, Przemysław R., Brum, Wagner S., Zetterberg, Henrik, Blennow, Kaj, Karikari, Thomas K.
Publicado 2023

Diagnostic value of serum versus plasma phospho-tau for Alzheimer’s disease

por Kac, Przemysław R., Gonzalez-Ortiz, Fernando, Simrén, Joel, Dewit, Nele, Vanmechelen, Eugeen, Zetterberg, Henrik, Blennow, Kaj, Ashton, Nicholas J., Karikari, Thomas K.
Publicado 2022

Association of Serum Brain-Derived Tau With Clinical Outcome and Longitudinal Change in Patients With Severe Traumatic Brain Injury

por Gonzalez-Ortiz, Fernando, Dulewicz, Maciej, Ashton, Nicholas J., Kac, Przemysław R., Zetterberg, Henrik, Andersson, Emma, Yakoub, Yara, Hanrieder, Jörg, Turton, Michael, Harrison, Peter, Nellgård, Bengt, Karikari, Thomas K., Blennow, Kaj
Publicado 2023

Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegeneration

por Gonzalez-Ortiz, Fernando, Turton, Michael, Kac, Przemysław R, Smirnov, Denis, Premi, Enrico, Ghidoni, Roberta, Benussi, Luisa, Cantoni, Valentina, Saraceno, Claudia, Rivolta, Jasmine, Ashton, Nicholas J, Borroni, Barbara, Galasko, Douglas, Harrison, Peter, Zetterberg, Henrik, Blennow, Kaj, Karikari, Thomas K
Publicado 2022

Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring

por Ashton, Nicholas J., Janelidze, Shorena, Mattsson-Carlgren, Niklas, Binette, Alexa Pichet, Strandberg, Olof, Brum, Wagner S., Karikari, Thomas K., González-Ortiz, Fernándo, Di Molfetta, Guglielmo, Meda, Francisco J., Jonaitis, Erin M., Koscik, Rebecca Langhough, Cody, Karly, Betthauser, Tobey J., Li, Yan, Vanmechelen, Eugeen, Palmqvist, Sebastian, Stomrud, Erik, Bateman, Randall J., Zetterberg, Henrik, Johnson, Sterling C., Blennow, Kaj, Hansson, Oskar
Publicado 2022